We are live on ! Find out more
AGTC

Applied Genetic Technologies Corporation
AGTC

Delisted

AGTC was delisted on the 30th of November, 2022.

Back to rankings

62 hedge funds and large institutions have $30M invested in Applied Genetic Technologies Corporation in 2017 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 10 increasing their positions, 24 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

7% less funds holding

Funds holding: 67 → 62 (-5)

11% less capital invested

Capital invested by funds: $33.6M → $30M (-$3.56M)

29% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 14

58% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 24

Holders
62
Holders Change
-5
Holders Change %
-7.46%
% of All Funds
1.41%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
10
Increased
10
Reduced
24
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
6CM
683 Capital Management
New York
+$816K
2
MERSOM
Municipal Employees' Retirement System of Michigan
Michigan
+$471K
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$429K
4
Renaissance Technologies
Renaissance Technologies
New York
+$412K
5
SIM
Spark Investment Management
New York
+$224K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$724K
2
Millennium Management
Millennium Management
New York
-$394K
3
GCP
GSA Capital Partners
United Kingdom
-$332K
4
AL
AJO LP
Pennsylvania
-$241K
5
American Century Companies
American Century Companies
Missouri
-$222K
Name Holding Trade Value Shares
Change 		Change in
Stake
Wells Fargo
51
Wells Fargo
California
$12K -$19.1K -5,047 -61%
Royal Bank of Canada
52
Royal Bank of Canada
Ontario, Canada
$7K – – –
IP
53
Intellectus Partners
California
$7K +$7.55K +2,000 New
ClearBridge Investments
54
ClearBridge Investments
New York
$4K – – –
Federated Hermes
55
Federated Hermes
Pennsylvania
$4K – – –
MAM
56
Meeder Asset Management
Ohio
$3K – – –
JP Morgan Chase
57
JP Morgan Chase
New York
$3K +$3.47K +920 New
Simplex Trading
58
Simplex Trading
Illinois
$3K +$3.61K +957 New
BNP Paribas Financial Markets
59
BNP Paribas Financial Markets
France
$1.8K – – –
MA
60
MUFG Americas
New York
$1K -$510 -135 -38%
QI
61
QS Investors
New York
$1K – – –
American Century Companies
62
American Century Companies
Missouri
– -$222K -56,143 Closed
Invesco
63
Invesco
Georgia
– -$67K -16,950 Closed
PCM
64
Prelude Capital Management
New York
– -$63K -15,900 Closed
SGAM
65
Smith Group Asset Management
Texas
– -$52K -13,080 Closed
ARTA
66
A.R.T. Advisors
New York
– -$49K -12,585 Closed
Walleye Trading
67
Walleye Trading
New York
– -$46 -11,677 Closed
EA
68
Emerald Advisers
Pennsylvania
– -$43K -10,875 Closed
Barclays
69
Barclays
United Kingdom
– -$39.3K -10,400 -99%
WS
70
Wedbush Securities
California
– -$40K -10,190 Closed
TRCT
71
Tower Research Capital (TRC)
New York
– -$26K -6,656 Closed
NFA
72
Nationwide Fund Advisors
Ohio
– -$5K -1,200 Closed
IA
73
IFP Advisors
Florida
– -$4K -1,000 Closed
IWM
74
IHT Wealth Management
Illinois
– -$3K -661 Closed
AIM
75
Advantage Investment Management
Iowa
– -$3K -640 Closed
1 2
3
4

AGTC Hedge Fund Activity: Q4 2017 in Review

62 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Applied Genetic Technologies Corporation (AGTC) for Q4 2017, worth a combined $30M — down 11% from $33.6M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of AGTC and 10 opened new positions — a net loss of 4 holders — while 24 trimmed existing stakes and 10 added.

The largest buyer was 683 Capital Management, opening a new position worth an estimated $816K. The largest seller was Fidelity Investments, cutting an estimated $724K.

  • 62 institutional investors held Applied Genetic Technologies Corporation (AGTC) as of Q4 2017, down from 67 in Q3 2017.
  • Funds reported $30M of Applied Genetic Technologies Corporation stock for Q4 2017, down 11% quarter-over-quarter.
  • 10 funds opened new Applied Genetic Technologies Corporation positions in Q4 2017 and 14 closed out, a net change of -4 holders.
  • The largest Applied Genetic Technologies Corporation buyer in Q4 2017 was 683 Capital Management, an estimated $816K added.
  • The largest Applied Genetic Technologies Corporation seller in Q4 2017 was Fidelity Investments, an estimated $724K sold.

Based on aggregated 13F filings for Q4 2017.